Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
4.010
-0.080 (-1.96%)
At close: Aug 21, 2026, 4:00 PM EDT
4.020
+0.010 (0.25%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Adagene Employees
Adagene had 128 employees as of December 31, 2025. The number of employees decreased by 10 or -7.25% compared to the previous year.
Employees
128
Change (1Y)
-10
Growth (1Y)
-7.25%
Revenue / Employee
$72,584
Profits / Employee
-$160,242
Market Cap
269.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | -10 | -7.25% |
| Dec 31, 2024 | 138 | -36 | -20.69% |
| Dec 31, 2023 | 174 | -74 | -29.84% |
| Dec 31, 2022 | 248 | -11 | -4.25% |
| Dec 31, 2021 | 259 | 61 | 30.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Entrada Therapeutics | 152 |
| Invivyd | 122 |
| AC Immune | 122 |
| Lineage Cell Therapeutics | 77 |
| Neumora Therapeutics | 63 |
| ALX Oncology Holdings | 48 |
| Camp4 Therapeutics | 48 |
| Surrozen | 44 |
ADAG News
- 2 days ago - Adagene to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 6 weeks ago - Adagene Slides: Corporate presentation - Filings
- 3 months ago - Adagene Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 3 months ago - Adagene Slides: Investor presentation - Filings
- 3 months ago - Adagene to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR - TheFly
- 4 months ago - Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types - GlobeNewsWire